Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Nasopharyngeal Carcinoma 20Carcinoma, Non-Small-Cell Lung 18Esophageal Squamous Cell Carcinoma 15Breast Neoplasms 14Triple Negative Breast Neoplasms 13Squamous Cell Carcinoma of Head and Neck 11Carcinoma, Hepatocellular 11Stomach Neoplasms 8Small Cell Lung Carcinoma 8Uterine Cervical Neoplasms 6Recurrence 6Head and Neck Neoplasms 6Colorectal Neoplasms 6Carcinoma, Transitional Cell 5Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 4Sarcoma 4Rectal Neoplasms 4Neoplasm Metastasis 4Melanoma 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Locally Advanced Rectal Cancer 3Liver Neoplasms 3Turcot syndrome 2Pathologic Complete Response 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2

Interventions

Cisplatin 20Cetuximab 11Carboplatin 9Specimen Handling 8Radiotherapy 8Docetaxel 8Radiotherapy, Intensity-Modulated 7Magnetic Resonance Spectroscopy 71,2-diaminocyclohexaneplatinum II citrate 7Platinum 6Fluorouracil 6pembrolizumab 5Radiation 5toripalimab 4Paclitaxel 4cemiplimab 3X-Rays 3Surgical Procedures, Operative 3Celecoxib 3Biopsy 3130-nm albumin-bound paclitaxel 3Taxes 2Standard of Care 2Radiotherapy, Image-Guided 2Hydroxyurea 2Drug Therapy 2tislelizumab 1sodium thiosulfate 1sargramostim 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Laryngeal Neoplasms × toripalimab × Clear all
NCT07209189 2026-04-23

(NeoScorch HN)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
75 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT06039631 2023-09-15

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

Fudan University

Phase 2 Recruiting
82 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT05420597 2022-06-15

Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma

Fudan University

Phase 2 Unknown
61 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT04995120 2022-01-18

INSIGHT

Fudan University

Phase 2 Unknown
42 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡